Melanoma cancer is a type of skin cancer that develops from melanocytes, pigment cells. Extreme exposure to ultraviolet rays leading to sunburn causes melanoma. Melanoma cancer is categorised into mucosal cutaneous and ocular. In cutaneous melanoma the skin is affected, while mucus membrane is affected in mucosal melanoma and ocular melanoma affects the eyes. Early detection of melanoma can increase survival rate by helping in treatment. In 2015, the American Academy of Dermatology reported that melanoma cases are increasing and it further spreads to other body parts, which makes the treatment more complex. The risk of melanoma cancer is also increased by genetic conditions such as xeroderma pigmentosum.
Get FREE Sample Report with Latest Covid19 Impact Analysis
Increasing cases of melanoma are expected to propel growth of the global melanoma treatment market. For instance, in 2016, Cancer Research Institute reported 76,000 people were suffering melanoma in the U.S.
Increasing approvals, development of new drugs, and combination therapies is expected to boost growth of the global melanoma treatment market. For instance, in 2011, the U.S. FDA granted approval to Bristol-Myers Squibb’s Yervoy, which is a monoclonal antibody drug developed for melanoma treatment.
Many of the drugs that are under development such as Amgen Inc.’s talimogene laherparepvec (T-VEC), seviprotimut-L by Polynoma’s, and zelboraf, by Roche and Genetech are already approved by FDA.
High cost of combination therapies and clinical trials with side effects are expected to hamper growth of the global melanoma treatment market.
Increasing focus on personalised drugs and increasing investment in anti-melanoma drugs are expected to create a lucrative opportunities for market players in the melanoma treatment market.
Get PDF Brochure with Latest Insights
The global melanoma treatment market is divided into melanoma type, and therapy.
By Melanoma Type:
Melanoma treatment market regionally divided into North America, Europe, Latin America, Middle East, Asia Pacific, and Africa.
Among regions, North America is expected to witness substantial growth in the melanoma treatment market, owing to increasing cases of melanoma, well-established healthcare facilities, growing R&D on melanoma medicines, reimbursement policies and increasing incomer per capita.
Moreover, Europe is expected to witness significant growth in the in the melanoma treatment market due to growing occurrence of melanoma and development of new treatments.
Asia Pacific is expected to witness growth in the melanoma treatment market, owing to low awareness, high-cost melanoma medications and lesser cases of skin cancer.
Major players functioning in the global melanoma treatment market comprise F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca, Sanofi, Takeda Pharmaceutical Company, Bristol-Myers Squibb, Genetech Inc., Polynoma LLC, Amgen Inc., and Merck & Co. Inc.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/719
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Melanoma Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Melanoma Treatment Industry Impact
Chapter 2 Global Melanoma Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Melanoma Treatment (Volume and Value) by Type
2.3 Global Melanoma Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Melanoma Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Melanoma Treatment Market Analysis
Chapter 6 East Asia Melanoma Treatment Market Analysis
Chapter 7 Europe Melanoma Treatment Market Analysis
Chapter 8 South Asia Melanoma Treatment Market Analysis
Chapter 9 Southeast Asia Melanoma Treatment Market Analysis
Chapter 10 Middle East Melanoma Treatment Market Analysis
Chapter 11 Africa Melanoma Treatment Market Analysis
Chapter 12 Oceania Melanoma Treatment Market Analysis
Chapter 13 South America Melanoma Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Melanoma Treatment Business
Chapter 15 Global Melanoma Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027